Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
Markets
/
Stocks
/
nasdaq-lona
/
LeonaBio Ord Shs
LONA
9.170
USD
-0.510
-5.27%
Market hours (ET)
Quotes delayed by 15 min
USD
0.000
Pre-market (ET)
35.80M
Market Cap
Loss
P/E TTM
LeonaBio Ord Shs
9.170
-0.510
-5.27%
Overview
Financials
Analysis
Company
Overview
Financials
Analysis
Company
More Details of Company
LeonaBio Ord Shs Info
Ticker Symbol
- -
Company name
- -
IPO date
- -
CEO
- -
Number of employees
- -
Security type
- -
Fiscal year-end
- -
Address
- -
City
- -
Stock exchange
- -
Country
- -
Postal code
- -
Phone
- -
Website
- -
Ticker Symbol
- -
IPO date
- -
CEO
- -
Company Executives of LeonaBio Ord Shs
Name
Name/Position
Position
Shareholding
Change
Dr. Mark James Litton, Ph.D.
Dr. Mark James Litton, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
59.89K
+28.55%
Dr. Kevin Church, Ph.D.
Dr. Kevin Church, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
25.18K
+17.86%
Mr. Mark Worthington
Mr. Mark Worthington
Chief Compliance Officer, General Counsel, Company Secretary
Chief Compliance Officer, General Counsel, Company Secretary
18.38K
+23.93%
Dr. Javier San Martin, M.D.
Dr. Javier San Martin, M.D.
Chief Medical Officer
Chief Medical Officer
15.89K
+35.87%
Mr. Robert Renninger
Mr. Robert Renninger
Senior Vice President - Finance, Accounting
Senior Vice President - Finance, Accounting
15.85K
+18.89%
Ms. Kelly A. Romano
Ms. Kelly A. Romano
Independent Chairwoman of the Board
Independent Chairwoman of the Board
8.07K
-0.01%
Mr. Grant E. Pickering
Mr. Grant E. Pickering
Independent Director
Independent Director
2.58K
--
James A. Johnson ,
James A. Johnson ,
Independent Director
Independent Director
500.00
--
Ms. Barbara Kosacz, J.D.
Ms. Barbara Kosacz, J.D.
Independent Director
Independent Director
--
--
Mr. Joseph (Joe) Edelman
Mr. Joseph (Joe) Edelman
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Mark James Litton, Ph.D.
Dr. Mark James Litton, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
59.89K
+28.55%
Dr. Kevin Church, Ph.D.
Dr. Kevin Church, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
25.18K
+17.86%
Mr. Mark Worthington
Mr. Mark Worthington
Chief Compliance Officer, General Counsel, Company Secretary
Chief Compliance Officer, General Counsel, Company Secretary
18.38K
+23.93%
Dr. Javier San Martin, M.D.
Dr. Javier San Martin, M.D.
Chief Medical Officer
Chief Medical Officer
15.89K
+35.87%
Mr. Robert Renninger
Mr. Robert Renninger
Senior Vice President - Finance, Accounting
Senior Vice President - Finance, Accounting
15.85K
+18.89%
Ms. Kelly A. Romano
Ms. Kelly A. Romano
Independent Chairwoman of the Board
Independent Chairwoman of the Board
8.07K
-0.01%
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Wed, Mar 11
Updated: Wed, Mar 11
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Perceptive Advisors LLC
19.92%
Acorn Capital Advisors, LLC
6.38%
New Enterprise Associates (NEA)
4.97%
TCG Crossover Management, LLC
4.97%
Commodore Capital LP
4.97%
Other
58.78%
Shareholders
Shareholders
Proportion
Perceptive Advisors LLC
19.92%
Acorn Capital Advisors, LLC
6.38%
New Enterprise Associates (NEA)
4.97%
TCG Crossover Management, LLC
4.97%
Commodore Capital LP
4.97%
Other
58.78%
Shareholder Types
Shareholders
Proportion
Investment Advisor
25.56%
Private Equity
20.15%
Hedge Fund
13.59%
Venture Capital
6.57%
Corporation
2.54%
Investment Advisor/Hedge Fund
2.37%
Individual Investor
1.99%
Research Firm
0.50%
Family Office
0.41%
Other
26.31%
Institutional Shareholding
Updated: Tue, Jan 13
Updated: Tue, Jan 13
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
107
3.43M
86.99%
+588.35K
2025Q4
113
3.34M
84.61%
+1.00M
2025Q3
123
1.85M
47.14%
-805.95K
2025Q2
137
1.88M
48.34%
-780.64K
2025Q1
169
1.88M
48.36%
-912.05K
2024Q4
181
1.93M
49.87%
-1.07M
2024Q3
198
1.93M
50.33%
-1.16M
2024Q2
215
2.54M
66.42%
-582.38K
2024Q1
233
2.49M
65.12%
-1.23M
2023Q4
240
2.51M
65.92%
-1.08M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Perceptive Advisors LLC
1.86M
47.14%
+1.32M
+244.13%
Dec 23, 2025
Acorn Capital Advisors, LLC
501.74K
12.72%
+501.74K
--
Dec 22, 2025
Simplify Asset Management Inc
298.56K
7.57%
--
--
Sep 30, 2025
View more
Related ETFs
Updated: Tue, Jan 13
Updated: Tue, Jan 13
Name
Proportion
Simplify Propel Opportunities ETF
1.54%
Dimensional US Core Equity 1 ETF
0%
iShares US Small-Cap Equity Factor ETF
0%
iShares Micro-Cap ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Neuroscience and Healthcare ETF
0%
Avantis US Small Cap Equity ETF
0%
Simplify Propel Opportunities ETF
Proportion
1.54%
Dimensional US Core Equity 1 ETF
Proportion
0%
iShares US Small-Cap Equity Factor ETF
Proportion
0%
iShares Micro-Cap ETF
Proportion
0%
DFA Dimensional US Sustainability Core 1 ETF
Proportion
0%
iShares Neuroscience and Healthcare ETF
Proportion
0%
Avantis US Small Cap Equity ETF
Proportion
0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI
Please log in to use KeyAI
Log in
Start for free